初级IgA脏病的治疗:改变,改变,改变
Dawn J Caster1, Richard A Lafayette2
1Division of Nephrology and Hypertension, University of Louisville, Louisville, Kentucky.
概括
IgA 病 (IgAN) 治疗正在随着新疗法和支持性药物而发展. 本综述讨论了当前的方法,新兴的治疗方法,如SGLT2抑制剂,以及Igan管理的未来方向.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學專業.
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 在全球范围内,IgA脏病 (IgAN) 是最常见的淋巴细胞疾病.
- 目前针对Igan的治疗策略缺乏普遍共识.
- 最近的进展包括新药批准和广泛的临床试验.
研究的目的:
- 概述 IgA 病的当代治疗方法.
- 识别IGAN管理中的知识差距.
- 讨论IGAN的新兴和新的治疗策略.
主要方法:
- 审查最近的临床试验和IgAN的治疗发展.
- 分析既有和新型治疗方法的疗效.
- 讨论新的Igan疗法的病理生理目标.
主要成果:
- 皮质类固醇的使用继续被检查,与新批准的疗法一起.
- 糖共传输体2 (SGLT2) 抑制剂在蛋白尿性脏疾病中表现有前途,包括IgAN.
- 目前正在调查针对内素,补充剂和B细胞的新型药物.
结论:
- 对Igan的治疗环境正在迅速变化和扩大.
- 优化利用新的Igan疗法需要进一步的证据.
- 伊干治疗的未来是充满活力和希望的,有多种新的策略在地平线上.
相关概念视频
Nephrotic Syndrome III : Nursing Management
19
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
19
Chronic Kidney Disease III: Interprofessional Care
28
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
28
Nephrotic Syndrome II : Assessment and Medical Management
8
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
8
Acute Kidney Injury V: Interprofessional Care
12
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
12
Acute Kidney Injury IV: Diagnostic Studies and Prevention
21
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
21
Open Angle Glaucoma: Treatment
474
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
474


